BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Henamayee S, Banik K, Sailo BL, Shabnam B, Harsha C, Srilakshmi S, Vgm N, Baek SH, Ahn KS, Kunnumakkara AB. Therapeutic Emergence of Rhein as a Potential Anticancer Drug: A Review of Its Molecular Targets and Anticancer Properties. Molecules 2020;25:E2278. [PMID: 32408623 DOI: 10.3390/molecules25102278] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 24.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu S, Yin R, Yang Z, Wei F, Hu J. The effects of rhein on D-GalN/LPS-induced acute liver injury in mice: Results from gut microbiome-metabolomics and host transcriptome analysis. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.971409] [Reference Citation Analysis]
2 Jayaprakash S, Hegde M, BharathwajChetty B, Girisa S, Alqahtani MS, Abbas M, Sethi G, Kunnumakkara AB. Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer. Int J Mol Sci 2022;23:12380. [PMID: 36293239 DOI: 10.3390/ijms232012380] [Reference Citation Analysis]
3 Zhu Y, Yang S, Lv L, Zhai X, Wu G, Qi X, Dong D, Tao X. Research Progress on the Positive and Negative Regulatory Effects of Rhein on the Kidney: A Review of Its Molecular Targets. Molecules 2022;27:6572. [PMID: 36235108 DOI: 10.3390/molecules27196572] [Reference Citation Analysis]
4 Aswathy M, Vijayan A, Daimary UD, Girisa S, Radhakrishnan KV, Kunnumakkara AB. Betulinic acid: A natural promising anticancer drug, current situation, and future perspectives. J Biochem Mol Toxicol 2022;:e23206. [PMID: 36124371 DOI: 10.1002/jbt.23206] [Reference Citation Analysis]
5 Wang Y, Yu F, Li A, He Z, Qu C, He C, Ma X, Zhan H. The progress and prospect of natural components in rhubarb (Rheum ribes L.) in the treatment of renal fibrosis. Front Pharmacol 2022;13:919967. [DOI: 10.3389/fphar.2022.919967] [Reference Citation Analysis]
6 Li R, Xu J, Zhang Z, Chen M, Liu S, Yang C, Li Y, Luo P, Liu Y, Tang R, Shan Z. Rhein ameliorates transverse aortic constriction-induced cardiac hypertrophy via regulating STAT3 and p38 MAPK signaling pathways. Front Pharmacol 2022;13:940574. [DOI: 10.3389/fphar.2022.940574] [Reference Citation Analysis]
7 Wang X, Zheng Y, Qiu L, Ouyang H, Xu X, Xu W, Zhang Y, Xu W. Evaluation and antitumor mechanism of functionalized chitosan-based polymeric micelles for oral delivery of paclitaxel. Int J Pharm 2022;625:122138. [PMID: 36029990 DOI: 10.1016/j.ijpharm.2022.122138] [Reference Citation Analysis]
8 Venkat R, Verma E, Daimary UD, Kumar A, Girisa S, Dutta U, Ahn KS, Kunnumakkara AB. The journey of resveratrol from vineyards to clinics. Cancer Invest 2022;:1-66. [PMID: 35993769 DOI: 10.1080/07357907.2022.2115057] [Reference Citation Analysis]
9 Khatoon E, Hegde M, Kumar A, Daimary UD, Sethi G, Bishyaee A, Kunnumakkara AB. The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer. Arch Pharm Res . [DOI: 10.1007/s12272-022-01398-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Sajeev A, Hegde M, Daimary UD, Kumar A, Girisa S, Sethi G, Kunnumakkara AB. Modulation of diverse oncogenic signaling pathways by oroxylin A: An important strategy for both cancer prevention and treatment. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Trybus W, Król T, Trybus E. Rhein induces changes in the lysosomal compartment of HeLa cells. J Cell Biochem 2022. [PMID: 35901236 DOI: 10.1002/jcb.30311] [Reference Citation Analysis]
12 Song N, Cui K, Zhang K, Yang J, Liu J, Miao Z, Zhao F, Meng H, Chen L, Chen C, Li Y, Shao M, Zhang J, Wang H. The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research. Front Pharmacol 2022;13:933332. [DOI: 10.3389/fphar.2022.933332] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Yang D, Wang H, Liu Q, Yuan P, Chen T, Zhang L, Yang S, Zhou Z, Lu Y, Du G. Structural landscape on a series of rhein: Berberine cocrystal salt solvates: The formation, dissolution elucidation from experimental and theoretical investigations. Chinese Chemical Letters 2022;33:3207-11. [DOI: 10.1016/j.cclet.2021.10.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
14 Folliero V, Dell’annunziata F, Roscetto E, Amato A, Gasparro R, Zannella C, Casolaro V, De Filippis A, Catania MR, Franci G, Galdiero M. Rhein: A Novel Antibacterial Compound Against Streptococcus mutans Infection. Microbiological Research 2022. [DOI: 10.1016/j.micres.2022.127062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
15 Gabano E, Gariboldi MB, Caron G, Ermondi G, Marras E, Vallaro M, Ravera M. Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(IV) complexes to obtain antiproliferative agents against human glioblastoma cells. Dalton Trans 2022;51:6014-26. [PMID: 35352739 DOI: 10.1039/d2dt00235c] [Reference Citation Analysis]
16 Parama D, Girisa S, Khatoon E, Kumar A, Alqahtani MS, Abbas M, Sethi G, Kunnumakkara AB. An Overview of the Pharmacological Activities of Scopoletin against Different Chronic Diseases. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106202] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
17 Jang JY, Sung B, Kim ND. Role of Induced Programmed Cell Death in the Chemopreventive Potential of Apigenin. Int J Mol Sci 2022;23:3757. [PMID: 35409117 DOI: 10.3390/ijms23073757] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
18 Banik K, Khatoon E, Harsha C, Rana V, Parama D, Thakur KK, Bishayee A, Kunnumakkara AB. Wogonin and its analogs for the prevention and treatment of cancer: A systematic review. Phytotherapy Research. [DOI: 10.1002/ptr.7386] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
19 Yang H, Zhai B, Wang M, Fan Y, Wang J, Cheng J, Zou J, Zhang X, Shi Y, Guo D, Tang Z. The influence of rhein on the absorption of rehmaionoside D: In vivo, in situ, in vitro, and in silico studies. J Ethnopharmacol 2022;282:114650. [PMID: 34536515 DOI: 10.1016/j.jep.2021.114650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Wu L, Shi Y, Ni Z, Yu T, Chen Z. Preparation of a Self-Assembled Rhein-Doxorubicin Nanogel Targeting Mitochondria and Investigation on Its Antihepatoma Activity. Mol Pharm 2022;19:35-50. [PMID: 34890210 DOI: 10.1021/acs.molpharmaceut.1c00565] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Hekmat A, Saboury AA. Protein kinase inhibitors and cancer targeted therapy. Protein Kinase Inhibitors 2022. [DOI: 10.1016/b978-0-323-91287-7.00022-3] [Reference Citation Analysis]
22 Rana V, Parama D, Khatoon E, Girisa S, Sethi G, Kunnumakkara AB. Reiterating the Emergence of Noncoding RNAs as Regulators of the Critical Hallmarks of Gall Bladder Cancer. Biomolecules 2021;11:1847. [PMID: 34944491 DOI: 10.3390/biom11121847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
23 Abdel-latif RT, Wadie W, Abdel-mottaleb Y, Abdallah DM, El-maraghy NN, El-abhar HS. Reposition of the anti-inflammatory drug diacerein in an in-vivo colorectal cancer model. Saudi Pharmaceutical Journal 2021. [DOI: 10.1016/j.jsps.2021.12.009] [Reference Citation Analysis]
24 Devi Daimary U, Girisa S, Parama D, Verma E, Kumar A, Kunnumakkara AB. Embelin: A novel XIAP inhibitor for the prevention and treatment of chronic diseases. J Biochem Mol Toxicol 2021;:e22950. [PMID: 34842329 DOI: 10.1002/jbt.22950] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Zheng Y, Liu Z, Yang X, Liu L, Ahn KS. An updated review on the potential antineoplastic actions of oleuropein. Phytother Res 2021. [PMID: 34808696 DOI: 10.1002/ptr.7325] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
26 Verma E, Kumar A, Devi Daimary U, Parama D, Girisa S, Sethi G, Kunnumakkara AB. Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review. Journal of Functional Foods 2021;86:104660. [DOI: 10.1016/j.jff.2021.104660] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
27 Banik K, Khatoon E, Hegde M, Thakur KK, Puppala ER, Naidu VGM, Kunnumakkara AB. A novel bioavailable curcumin-galactomannan complex modulates the genes responsible for the development of chronic diseases in mice: A RNA sequence analysis. Life Sci 2021;287:120074. [PMID: 34687757 DOI: 10.1016/j.lfs.2021.120074] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
28 Kumar A, Harsha C, Parama D, Girisa S, Daimary UD, Mao X, Kunnumakkara AB. Current clinical developments in curcumin-based therapeutics for cancer and chronic diseases. Phytother Res 2021. [PMID: 34498308 DOI: 10.1002/ptr.7264] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
29 Ooi SL, Pak SC. Nutraceuticals in Immune Function. Molecules 2021;26:5310. [PMID: 34500743 DOI: 10.3390/molecules26175310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Parama D, Rana V, Girisa S, Verma E, Daimary UD, Thakur KK, Kumar A, Kunnumakkara AB. The promising potential of piperlongumine as an emerging therapeutics for cancer. Exploration of Targeted Anti-tumor Therapy. [DOI: 10.37349/etat.2021.00049] [Reference Citation Analysis]
31 Feng X, Luo Y, Li F, Jian X, Liu Y. Development of Natural-Drugs-Based Low-Molecular-Weight Supramolecular Gels. Gels 2021;7:105. [PMID: 34449606 DOI: 10.3390/gels7030105] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
32 Girisa S, Henamayee S, Parama D, Rana V, Dutta U, Kunnumakkara AB. Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer. Mol Biomed 2021;2:21. [PMID: 35006466 DOI: 10.1186/s43556-021-00035-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
33 Girisa S, Saikia Q, Bordoloi D, Banik K, Monisha J, Daimary UD, Verma E, Ahn KS, Kunnumakkara AB. Xanthohumol from Hop: Hope for cancer prevention and treatment. IUBMB Life 2021;73:1016-44. [PMID: 34170599 DOI: 10.1002/iub.2522] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
34 Tuğrak M, Gül Hİ, Sakagami H, Kaya R, Gülçin İ. Synthesis and biological evaluation of new pyrazolebenzene-sulphonamides as potential anticancer agents and hCA I and II inhibitors. Turk J Chem 2021;45:528-39. [PMID: 34385849 DOI: 10.3906/kim-2009-37] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Girisa S, Rana V, Parama D, Dutta U, Kunnumakkara AB. Differential roles of farnesoid X receptor (FXR) in modulating apoptosis in cancer cells. Adv Protein Chem Struct Biol 2021;126:63-90. [PMID: 34090620 DOI: 10.1016/bs.apcsb.2021.02.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Luo R, Lin M, Fu C, Zhang J, Chen Q, Zhang C, Shi J, Pu X, Dong L, Xu H, Ye N, Sun J, Lin D, Deng B, McDowell A, Fu S, Gao F. Calcium pectinate and hyaluronic acid modified lactoferrin nanoparticles loaded rhein with dual-targeting for ulcerative colitis treatment. Carbohydr Polym 2021;263:117998. [PMID: 33858583 DOI: 10.1016/j.carbpol.2021.117998] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 17.0] [Reference Citation Analysis]
37 Girisa S, Kumar A, Rana V, Parama D, Daimary UD, Warnakulasuriya S, Kumar AP, Kunnumakkara AB. From Simple Mouth Cavities to Complex Oral Mucosal Disorders-Curcuminoids as a Promising Therapeutic Approach. ACS Pharmacol Transl Sci 2021;4:647-65. [PMID: 33860191 DOI: 10.1021/acsptsci.1c00017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
38 Aswathy M, Banik K, Parama D, Sasikumar P, Harsha C, Joseph AG, Sherin DR, Thanathu MK, Kunnumakkara AB, Vasu RK. Exploring the Cytotoxic Effects of the Extracts and Bioactive Triterpenoids from Dillenia indica against Oral Squamous Cell Carcinoma: A Scientific Interpretation and Validation of Indigenous Knowledge. ACS Pharmacol Transl Sci 2021;4:834-47. [PMID: 33860206 DOI: 10.1021/acsptsci.1c00011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
39 Kunnumakkara AB, Rana V, Parama D, Banik K, Girisa S, Henamayee S, Thakur KK, Dutta U, Garodia P, Gupta SC, Aggarwal BB. COVID-19, cytokines, inflammation, and spices: How are they related? Life Sci 2021;:119201. [PMID: 33607159 DOI: 10.1016/j.lfs.2021.119201] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 24.0] [Reference Citation Analysis]
40 Acharya B, Chaijaroenkul W, Na-Bangchang K. Therapeutic potential and pharmacological activities of β-eudesmol. Chem Biol Drug Des 2021;97:984-96. [PMID: 33449412 DOI: 10.1111/cbdd.13823] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
41 Ahmad B, Rehman SU, Azizullah A, Khan MF, Din SRU, Ahmad M, Ali A, Tahir N, Azam N, Gamallat Y, Rahman KU, Ali M, Safi M, Khan I, Qamer S, Oh DH. Molecular mechanisms of anticancer activities of polyphyllin VII. Chem Biol Drug Des 2021;97:914-29. [PMID: 33342040 DOI: 10.1111/cbdd.13818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Ashrafizadeh M, Gholami MH, Mirzaei S, Zabolian A, Haddadi A, Farahani MV, Kashani SH, Hushmandi K, Najafi M, Zarrabi A, Ahn KS, Khan H. Dual relationship between long non-coding RNAs and STAT3 signaling in different cancers: New insight to proliferation and metastasis. Life Sci 2021;270:119006. [PMID: 33421521 DOI: 10.1016/j.lfs.2020.119006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 29.0] [Reference Citation Analysis]
43 Mirzaei S, Zarrabi A, Asnaf SE, Hashemi F, Zabolian A, Hushmandi K, Raei M, Goharrizi MASB, Makvandi P, Samarghandian S, Najafi M, Ashrafizadeh M, Aref AR, Hamblin MR. The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators. Life Sci 2021;268:119005. [PMID: 33421526 DOI: 10.1016/j.lfs.2020.119005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 33.0] [Reference Citation Analysis]
44 Daimary UD, Parama D, Rana V, Banik K, Kumar A, Harsha C, Kunnumakkara AB. Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases. Current Research in Pharmacology and Drug Discovery 2021;2:100008. [DOI: 10.1016/j.crphar.2020.100008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 20.0] [Reference Citation Analysis]
45 Ahmed SA, Parama D, Daimari E, Girisa S, Banik K, Harsha C, Dutta U, Kunnumakkara AB. Rationalizing the therapeutic potential of apigenin against cancer. Life Sci 2021;267:118814. [PMID: 33333052 DOI: 10.1016/j.lfs.2020.118814] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 15.5] [Reference Citation Analysis]
46 Liu K, Zhang X, Xie L, Deng M, Chen H, Song J, Long J, Li X, Luo J. Lupeol and its derivatives as anticancer and anti-inflammatory agents: Molecular mechanisms and therapeutic efficacy. Pharmacol Res 2021;164:105373. [PMID: 33316380 DOI: 10.1016/j.phrs.2020.105373] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 15.5] [Reference Citation Analysis]
47 Baier A, Szyszka R. Compounds from Natural Sources as Protein Kinase Inhibitors. Biomolecules 2020;10:E1546. [PMID: 33198400 DOI: 10.3390/biom10111546] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
48 Girisa S, Parama D, Harsha C, Banik K, Kunnumakkara AB. Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer. Exploration of Targeted Anti-tumor Therapy 2020;1. [DOI: 10.37349/etat.2020.00019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
49 Moghadam ER, Ang HL, Asnaf SE, Zabolian A, Saleki H, Yavari M, Esmaeili H, Zarrabi A, Ashrafizadeh M, Kumar AP. Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives. Biomolecules 2020;10:E1374. [PMID: 32992587 DOI: 10.3390/biom10101374] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
50 Kang JK, Hyun CG. 4-Hydroxy-7-Methoxycoumarin Inhibits Inflammation in LPS-activated RAW264.7 Macrophages by Suppressing NF-κB and MAPK Activation. Molecules 2020;25:E4424. [PMID: 32993156 DOI: 10.3390/molecules25194424] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
51 Singh AK, Roy NK, Bordoloi D, Padmavathi G, Banik K, Khwairakpam AD, Kunnumakkara AB, Sukumar P. Orai-1 and Orai-2 regulate oral cancer cell migration and colonisation by suppressing Akt/mTOR/NF-κB signalling. Life Sci 2020;261:118372. [PMID: 32882268 DOI: 10.1016/j.lfs.2020.118372] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
52 Parama D, Boruah M, Yachna K, Rana V, Banik K, Harsha C, Thakur KK, Dutta U, Arya A, Mao X, Ahn KS, Kunnumakkara AB. Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases. Life Sci 2020;260:118182. [PMID: 32781063 DOI: 10.1016/j.lfs.2020.118182] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 26.5] [Reference Citation Analysis]